1.TREATMENT OF MAJORLIN`S ULCER: THE ROLE OF COMBINATION CHEMOTHERAPY.
Journal of the Korean Society of Plastic and Reconstructive Surgeons 1997;24(4):761-765
No abstract available.
Drug Therapy, Combination*
;
Ulcer*
2.5-fluorouracil, epirubicin, cisplatin(FEP) and 5-fluorouracil, cisplatin(FP) combination chemotherapy for advanced pancreatic carcinoma.
Ki Hyeong LEE ; Won Ki KANG ; Chang In SUH ; Young Suk PARK ; Heung Tae KIM ; Yoon Koo KANG ; Hyo Jin KIM ; Dae Seog HEO ; Yung Jue BANG ; Yong Bum YOON ; Noe Kyeong KIM ; Yong Hyun PARK
Journal of the Korean Cancer Association 1991;23(2):315-322
No abstract available.
Drug Therapy, Combination*
;
Epirubicin*
;
Fluorouracil*
3.Combination chemotherapy for the treatment of multiple myeloma.
Hyo Jin KIM ; Chang In SEO ; Keun Chil PARK ; Heung Tae KIM ; Dae Seog HEO ; Yung Hue BANG ; Seonyang PARK ; Byoung Kook KIM ; Noe Kyeong KIM
Journal of the Korean Cancer Association 1992;24(4):577-585
No abstract available.
Drug Therapy, Combination*
;
Multiple Myeloma*
4.COP-BLAM V(cyclophosphamide/vincristine/prednisolone/bleomycin/ adriamycin/procarbazine) combination chemotherapy for the treatment of intermediate and high grade non-Hodgkin's lymphoma.
Young Iee PARK ; Kee Heung LEE ; Keong Hae JUNG ; Sung Soo YOON ; Yeong Huck IM ; Jung Soon JANG ; Jae Yong LEE ; Dae Suck HEO ; Yung Jue BANG ; Seonyang PARK ; Byoung Kook KIM ; Noe Kyeong KIM
Journal of the Korean Cancer Association 1992;24(2):268-276
No abstract available.
Drug Therapy, Combination*
;
Lymphoma, Non-Hodgkin*
5.Mono- and Combination Chemotherapy for Metastatic Breast Cancer: An Increamental Step Forward.
Journal of Korean Breast Cancer Society 2003;6(3):137-140
No abstract available.
Breast Neoplasms*
;
Breast*
;
Drug Therapy, Combination*
6.The Relationship between MDR1 Polymorphisms and the Response to Etoposide/Cisplatin Combination Chemotherapy in Small Cell Lung Cancer.
Ji Woong SOHN ; Shin Yup LEE ; Su Jung LEE ; Hyo Sung JEON ; Jae Hee LEE ; Jae Hyung PARK ; Eun Jin KIM ; Seung Ick CHA ; Chang Ho KIM ; Young Mo KANG ; Jae Tae LEE ; Tae Hoon JUNG ; Jae Yong PARK
Tuberculosis and Respiratory Diseases 2005;58(2):135-141
No abstract available.
Drug Therapy, Combination*
;
Small Cell Lung Carcinoma*
7.Effect of combination therapy between sucrategel with amoxilline for Helicobacter pylori-induced chronic gastritis and for eradication of H. pylori: a histopathological study
Journal of Practical Medicine 2002;435(11):46-49
33 patients with H. pylori-induced chronic gastritis were treated by combination therapy with sucrategel and amoxicilline. Before and after treatment, the patients were given tests, included endoscopy and biopsy, histopathological test, urease test and culture for H. pylori. Histopathological findings before and after treatment were compared. The results showed that sucrategel plus amoxicilline combination was effective in H. pylori eradication in 51.51% of the patients. 42.42% of patients had remission in inflammatory or had normalization of gastric mucous membrane. For intestinal dysplasia, there was some improvement, but it was not concluded because of limitation in number of patients.
Gastritis
;
Helicobacter pylori
;
Drug Therapy, Combination
8.Modified COP-BLAM combination chemotherapy for the non-Hodgkin's lymphoma.
Journal of the Korean Cancer Association 1991;23(2):331-336
No abstract available.
Drug Therapy, Combination*
;
Lymphoma, Non-Hodgkin*
9.Treatment with augmented TAD combination chemotherapy and consolidation in patient with acute myelogenous leukemia.
Do Jin KIM ; Jung Sil WHANG ; Jong Ho WON ; Dae Sik HONG ; Hee Sook PARK ; Won Bae KIM
Journal of the Korean Cancer Association 1991;23(4):798-805
No abstract available.
Drug Therapy, Combination*
;
Humans
;
Leukemia, Myeloid, Acute*
10.COP-BLAM III(cyclophosphamide/vincristine/prednisolone/bleomycin/ adriamycin/procarbazine) combination chemotherapy for the treatment of intermediate and high grade non-Hodgkin's lymphoma.
Keong Hae JUNG ; Young Iee PARK ; Kee Heung LEE ; Young Suk PARK ; Chang In SUH ; Won Ki KANG ; Heung Tae KIM ; Cheol Won SUH ; Dae Seog HEO ; Yung Jue BANG ; Seonyang PARK ; Noe Kyeong KIM
Journal of the Korean Cancer Association 1992;24(4):586-595
No abstract available.
Drug Therapy, Combination*
;
Lymphoma, Non-Hodgkin*
Result Analysis
Print
Save
E-mail